Moreover, constitutive activation of the NF-κB pathway has been noted as a defining feature of PMBL, evidenced by an NF-κB transcriptional signature and by the nuclear translocation of NF-κB transcription factor complexes in the tumour cells. Here, NFKB1 is linked to neoplasm.